McKesson Will Centralize CDC Vaccine Distribution Program
This article was originally published in The Pink Sheet Daily
Contract will pay McKesson up to $95 mil. over five years.
You may also be interested in...
The previous administration’s forethought may have given the Trump team a leg up in vaccine distribution. McKesson’s experience as a central distributor for the Vaccines for Children’s program, H1N1 and its role in seasonal flu vaccine distribution should make it well positioned to handle the COVID-19 effort in the US, experts said.
CDC’s Advisory Committee on Immunization Practices recommends routine vaccination of girls ages 11 to 12 and a catch-up program for females ages 13 to 26 at its June 29 meeting.
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.